MedMen / Ascend dispute escalates

By Alex Halperin
Jan 6, 2022
MSO Ascend Wellness Holdings claimed MSO MedMen had challenged the authority of New York regulators. The accusation comes after MedMen announced, earlier this week, that it would terminate a deal to be sell more than 86% of its New York...

This content is FREE for registered users.

To view this content you need to register as a Weedweek member.

If you are already a member please login below.